Insights
Gain perspectives from experts on various policy issues and therapeutic areas through our Insights series that engages multiple managed care stakeholders in video interviews.
April 02, 2020 –
Describing the economic burden of migraines and how this neurological disease impacts healthcare costs.
March 31, 2020 –
Neil Goldfarb discusses migraine management in the workplace, where the condition ranks as a health concern.
March 27, 2020 –
The clinical and economic burden of advanced fibrosis due to nonalcoholic steatohepatitis on the health system, patients, and their family members.
March 27, 2020 –
Recommendations for monitoring and managing patients with advanced fibrosis caused by nonalcoholic steatohepatitis to reduce disease burden and prevent progression.
March 20, 2020 –
Drs Viviana Figueroa Diaz and Norman Sussman discuss the progressive nature of nonalcoholic steatohepatitis and highlight typical patient factors associated with risk of progression.
March 20, 2020 –
Recommendations for using noninvasive testing strategies and certain criteria when working with patients to make an accurate, definitive diagnosis of advanced fibrosis caused by nonalcoholic steatohepatitis.
March 13, 2020 –
Expert clinicians remark on the current role of the liver biopsy in the diagnosis of advanced fibrosis due to nonalcoholic steatohepatitis and highlight considerations for utilizing newer, noninvasive testing procedures instead.
March 13, 2020 –
Current and emerging techniques that can be utilized to help clinicians diagnose advanced fibrosis due to nonalcoholic steatohepatitis.
March 06, 2020 –
Barriers in care of patients with diabetic retinopathy and strategies available to increase easy access to care.
February 28, 2020 –
Experts review factors considered when deciding on treatment options and the complications associated with the available diabetic retinopathy therapies.
